Income Taxes	9 Months Ended
Apr. 01, 2017
Income Tax Disclosure [Abstract]
Income Taxes	Note 12. Income Taxes The Company recorded income tax expense of $4.3 million and $15.8 million related to income from continuing operations for the three and nine months ended April 1, 2017, respectively. The Company recorded income tax expense of $9.9 million and $13.9 million related to income from continuing operations for the three and nine months ended April 2, 2016, respectively. The income tax expense related to income from continuing operations recorded for the three and nine months ended April 1, 2017 and April 2, 2016 primarily relates to income tax in certain foreign and state jurisdictions based on the Company’s forecasted pre-tax income or loss for the respective year. In addition, for the three and nine months ended April 2, 2016, the Company’s income tax provision included a tax benefit of $7.6 million and $14.6 million, respectively, related to the income tax intraperiod tax allocation rules for discontinued operations and other comprehensive income. The income tax provision for the nine months ended April 2, 2016 included a tax expense of $8.9 million related to a one-time increase in valuation allowance associated with deferred tax assets transferred to Lumentum in connection with the Separation. The income tax expense related to income from continuing operations recorded differs from the expected tax expense that would be calculated by applying the federal statutory rate to the Company’s income from continuing operations before taxes primarily due to the changes in valuation allowance for deferred tax assets attributable to the Company’s domestic and foreign income (loss) from continuing operations, the income tax benefit recorded in continuing operations under the income tax intraperiod tax allocation rules, and the increase in valuation allowance associated with deferred tax assets transferred to Lumentum in connection with the separation. As of April 1, 2017 and July 2, 2016, the Company’s unrecognized tax benefits totaled $42.1 million and $41.7 million, respectively, and are included in deferred taxes and other non-current tax liabilities, net. The Company had $2.3 million accrued for the payment of interest and penalties at April 1, 2017. The unrecognized tax benefits that may be recognized during the next twelve months are approximately $1.0 million.

Note 12. Income Taxes

The Company recorded income tax expense of $4.3 million and $15.8 million related to income from continuing operations for the three and nine months ended April 1, 2017, respectively. The Company recorded income tax expense of $9.9 million and $13.9 million related to income from continuing operations for the three and nine months ended April 2, 2016, respectively.

The income tax expense related to income from continuing operations recorded for the three and nine months ended April 1, 2017 and April 2, 2016 primarily relates to income tax in certain foreign and state jurisdictions based on the Company’s forecasted pre-tax income or loss for the respective year. In addition, for the three and nine months ended April 2, 2016, the Company’s income tax provision included a tax benefit of $7.6 million and $14.6 million, respectively, related to the income tax intraperiod tax allocation rules for discontinued operations and other comprehensive income. The income tax provision for the nine months ended April 2, 2016 included a tax expense of $8.9 million related to a one-time increase in valuation allowance associated with deferred tax assets transferred to Lumentum in connection with the Separation.

The income tax expense related to income from continuing operations recorded differs from the expected tax expense that would be calculated by applying the federal statutory rate to the Company’s income from continuing operations before taxes primarily due to the changes in valuation allowance for deferred tax assets attributable to the Company’s domestic and foreign income (loss) from continuing operations, the income tax benefit recorded in continuing operations under the income tax intraperiod tax allocation rules, and the increase in valuation allowance associated with deferred tax assets transferred to Lumentum in connection with the separation.

As of April 1, 2017 and July 2, 2016, the Company’s unrecognized tax benefits totaled $42.1 million and $41.7 million, respectively, and are included in deferred taxes and other non-current tax liabilities, net. The Company had $2.3 million accrued for the payment of interest and penalties at April 1, 2017. The unrecognized tax benefits that may be recognized during the next twelve months are approximately $1.0 million.